For: | Ben Musa R, Gampa A, Basu S, Keshavarzian A, Swanson G, Brown M, Abraham R, Bruninga K, Losurdo J, DeMeo M, Mobarhan S, Shapiro D, Mutlu E. Hepatitis B vaccination in patients with inflammatory bowel disease. World J Gastroenterol 2014; 20(41): 15358-15366 [PMID: 25386085 DOI: 10.3748/wjg.v20.i41.15358] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v20/i41/15358.htm |
Number | Citing Articles |
1 |
Jason S. Reich, Francis A. Farraye, Sharmeel K. Wasan. Preventative Care in the Patient with Inflammatory Bowel Disease: What Is New?. Digestive Diseases and Sciences 2016; 61(8): 2205 doi: 10.1007/s10620-016-4146-x
|
2 |
Ji Young Chang, Sung-Ae Jung, Chang Mo Moon, Seong-Eun Kim, Hye-Kyung Jung, Ki-Nam Shim. Response to hepatitis B vaccination in patients with inflammatory bowel disease: a prospective observational study in Korea. Intestinal Research 2018; 16(4): 599 doi: 10.5217/ir.2018.00012
|
3 |
Giovanni Casella, Fabio Ingravalle, Adriana Ingravalle, Claudio Monti, Fulvio Bonetti, Federica De Salvatore, Vincenzo Villanacci, Aurelio Limonta. Vaccination in Inflammatory Bowel Disease: Utility and Future Perspective. Gastrointestinal Disorders 2020; 2(2): 175 doi: 10.3390/gidisord2020019
|
4 |
Webber Chan, Ennaliza Salazar, Teong Guan Lim, Wan Chee Ong, Hang Hock Shim. Vaccinations and inflammatory bowel disease – a systematic review. Digestive and Liver Disease 2021; 53(9): 1079 doi: 10.1016/j.dld.2021.04.015
|
5 |
Hong Yang, Zhihua Ran, Meng Jin, Jia-Ming Qian. Current Status of Opportunistic Infection in Inflammatory Bowel Disease Patients in Asia: A Questionnaire-Based Multicenter Study. Gut and Liver 2022; 16(5): 726 doi: 10.5009/gnl210217
|
6 |
Huyen-Tran Nguyen, Phillip Minar, Kimberly Jackson, Patricia C Fulkerson. Vaccinations in immunosuppressive-dependent pediatric inflammatory bowel disease. World Journal of Gastroenterology 2017; 23(42): 7644-7652 doi: 10.3748/wjg.v23.i42.7644
|
7 |
Ewa Waszczuk, Karolina M. Waszczuk, Agata Mulak, Leszek Paradowski. Inadequate seroprotection against hepatitis B virus and one detected case of hepatitis C virus infection among patients with inflammatory bowel disease. European Journal of Gastroenterology & Hepatology 2016; 28(6): 628 doi: 10.1097/MEG.0000000000000613
|
8 |
Amol Prabhakar Patil, Ebby George Simon, Amit Kumar Dutta, Anjilivelil Joseph Joseph, Reuben Thomas Kurien, Sudipta Dhar Chowdhury. Prevalence of serological markers of hepatitis B in inflammatory bowel disease – Experience from a tertiary care centre in South India. Tropical Doctor 2021; 51(3): 326 doi: 10.1177/00494755211015571
|
9 |
Suhyun Park, Sang Hyoung Park. Do We Have an Opportunity to Avoid Opportunistic Infections in Asian Patients with Inflammatory Bowel Disease?. Gut and Liver 2022; 16(5): 663 doi: 10.5009/gnl220364
|
10 |
J.K. Yamamoto-Furusho, A. Sarmiento-Aguilar, N.N. Parra-Holguín, K.E. Bozada-Gutiérrez. Evaluación del esquema de vacunación y cuidados con relación al seguimiento y tratamiento de los pacientes con enfermedad inflamatoria intestinal. Revista de Gastroenterología de México 2019; 84(1): 11 doi: 10.1016/j.rgmx.2018.02.003
|
11 |
Suprabhat Giri, Dhiraj Agrawal, Shivaraj Afzalpurkar, Sunil Kasturi, Amrit Gopan, Sridhar Sundaram, Aditya Kale. Prevalence of hepatitis B virus and hepatitis C virus infection in patients with inflammatory bowel disease: a systematic review and meta-analysis. Intestinal Research 2023; 21(3): 392 doi: 10.5217/ir.2022.00094
|
12 |
Hala H. Mansour, Ayman E. Eskander, Sara M. Osman, Normeen H. Rady. Incidence of Low Seroimmunity to Hepatitis B Virus in Children with Inflammatory Bowel Disease: A Single Center Experience. Pediatric Gastroenterology, Hepatology & Nutrition 2024; 27(2): 104 doi: 10.5223/pghn.2024.27.2.104
|
13 |
Georgios Axiaris, Evanthia Zampeli, Spyridon Michopoulos, Giorgos Bamias. Management of hepatitis B virus infection in patients with inflammatory bowel disease under immunosuppressive treatment. World Journal of Gastroenterology 2021; 27(25): 3762-3779 doi: 10.3748/wjg.v27.i25.3762
|
14 |
Ciara Egan, Glen A. Doherty. Why do we need to improve monitoring of patients with inflammatory bowel disease (IBD) on biologic treatment?. Expert Opinion on Biological Therapy 2019; 19(9): 907 doi: 10.1080/14712598.2019.1615050
|
15 |
Fotios S. Fousekis, Konstantinos H. Katsanos, Vasileios I. Theopistos, Gerasimos Baltayiannis, Maria Kosmidou, Georgios Glantzounis, Leonidas Christou, Epameinondas V. Tsianos, Dimitrios K. Christodoulou. Hepatobiliary and pancreatic manifestations in inflammatory bowel diseases: a referral center study. BMC Gastroenterology 2019; 19(1) doi: 10.1186/s12876-019-0967-3
|
16 |
Shuyi Feng, Saizheng Lin, Lingling Ma, Song Xu, Yan Chen. <p>Insufficient Knowledge and Vaccination Practice of Inflammatory Bowel Disease Patients in the People’s Republic of China</p>. Patient Preference and Adherence 2020; : 1513 doi: 10.2147/PPA.S265346
|
17 |
Mohammad Shehab, Fatema Alrashed, Munerah Alyaseen, Zainab Safar, Tunrayo Adekunle, Ahmad Alfadhli, Talat Bessissow. Immunogenicity of Hepatitis B Vaccination in Patients with Ulcerative Colitis on Infliximab Is Attenuated Compared to Those on 5-Aminosalicylic Acid Therapies: A Prospective Observational Study. Vaccines 2024; 12(4): 364 doi: 10.3390/vaccines12040364
|
18 |
J.K. Yamamoto-Furusho, A. Sarmiento-Aguilar, N.N. Parra-Holguín, K.E. Bozada-Gutiérrez. Evaluation of a vaccination regimen and care in relation to follow-up and treatment of patients with inflammatory bowel disease. Revista de Gastroenterología de México (English Edition) 2019; 84(1): 11 doi: 10.1016/j.rgmxen.2018.05.001
|